Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.20.2
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
6 Months Ended
Jun. 30, 2020
$ / shares
shares
Equity (Deficit):  
Number of warrants outstanding, beginning | shares 2,014,299
Number of warrants granted | shares 0
Number of warrants cancelled | shares 0
Number of warrants exercised | shares 0
Number of warrants forfeited | shares 0
Number of warrants outstanding, ending | shares 2,014,299
Number of warrants exercisable | shares 2,014,299
Weighted average exercise price outstanding, beginning $ 0.45
Weighted average exercise price granted 0
Weighted average exercise price cancelled 0
Weighted average exercise price exercised 0
Weighted average exercise price forfeited 0
Weighted average exercise price outstanding, ending 0.45
Weighted average exercise price exercisable 0.45
Weighted average fair value of warrants granted during the period $ 0.00
Weighted average remaining contractual life outstanding, beginning 3 years 3 months 22 days
Weighted average remaining contractual life outstanding, ending 2 years 9 months 22 days
Weighted average remaining contractual life exercisable 2 years 9 months 22 days